The hidden heart of autoimmunity: a scoping review of carditis in rheumatoid arthritis and IgG4-related disease
DOI:
https://doi.org/10.18203/2320-6012.ijrms20253649Keywords:
Carditis, Rheumatoid arthritis, IgG4-related disease, Autoimmune carditis, Myocarditis, Pericarditis, Endocarditis, Autoimmune disordersAbstract
Cardiac involvement in autoimmune diseases is often more common and more serious than we tend to acknowledge. While most clinicians are familiar with the joint pain of rheumatoid arthritis or the organ swelling of IgG4-related disease, inflammation of the heart itself is frequently missed. This is partly because cardiac symptoms are subtle or mistaken for something else, and partly because cardiovascular issues simply aren’t top of mind when managing autoimmune patients. As a result, carditis whether it's myocarditis, pericarditis, or pancarditis remains underdiagnosed, underreported, and under-discussed, especially in the context of rarer conditions. This gap in recognition is particularly noticeable in IgG4-related disease, a condition known for causing fibrotic masses and multiorgan inflammation, but where cardiac involvement is poorly documented and often misclassified. Even in rheumatoid arthritis (RA), a disease much more common and much better studied, direct inflammation of the heart is often overshadowed by more visible symptoms like synovitis or systemic fatigue. Yet, evidence suggests that cardiac complications significantly contribute to both morbidity and mortality in autoimmune patients, often silently progressing until they become life-threatening. This scoping review sets out to bring more attention to this overlooked aspect of autoimmune disease. We aim to explore and organise the current literature on carditis in RA and IgG4-related disease, looking closely at how it presents, how it's diagnosed, what mechanisms might be driving it, and how it's treated. We’ve taken a wide lens to capture everything from well-documented case reports and cohort studies to emerging data on biomarkers and imaging techniques. In the end, this review is not just about summarising the science. It’s about bringing the heart back into the conversation, literally and figuratively when we talk about autoimmune diseases. Because if we want to improve outcomes for these patients, we need to start looking beyond the obvious and paying closer attention to what’s happening inside the chest.
Metrics
References
Bulkley BH, Roberts WC. Ankylosing spondylitis and aortic regurgitation. Description of the characteristic cardiovascular lesion from study of eight necropsy patients. Circulation. 1973;48(5):1014-27. DOI: https://doi.org/10.1161/01.CIR.48.5.1014
Kvien TK, Glennås A, Knudsrød OG. Cardiac function in rheumatoid arthritis: Results from a population survey. Annals of the Rheumatic Diseases. 1987;46(9):661–6.
Thould AK. Constrictive pericarditis in rheumatoid arthritis. Ann Rheum Dis. 1986;45(2):89-94. DOI: https://doi.org/10.1136/ard.45.2.89
Wechalekar MD, Ngian GS, Lester S. Constrictive pericarditis as a presenting feature of rheumatoid arthritis. Heart. 2002;87(6):615.
Yoshida K, Ichikawa T, Nakamura T. Acute myocarditis associated with rheumatoid arthritis: An autopsy case. Circulation Journal. 2005;69(6):761–4.
Ntusi NA, Piechnik SK, Francis JM, Ferreira VM, Rai AB, Matthews PM, et al. Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis: A clinical study using myocardial T1-mapping and extracellular volume quantification. Journal of Cardiovascular Magnetic Resonance. 2014;16(1):21. DOI: https://doi.org/10.1186/1532-429X-16-21
Fine NM, Crowson CS, Lin G. Left ventricular dysfunction in rheumatoid arthritis: Detection by strain echocardiography and relationship to disease duration. Arthritis & Rheumatology. 2014;66(7):1964–71.
Youssef G, Chaudhry MA, Bakir M. Constrictive pericarditis as a complication of rheumatoid arthritis: A case report and literature review. European Heart Journal – Case Reports. 2020;4(6):1–6.
Zvaifler NJ, Fessel WJ, Bluestone R. Rheumatoid disease of the pericardium: A clinicopathologic study. American Journal of Medicine. 1973;55(1):25–35.
Ntusi NAB, Piechnik SK, Francis JM, Ferreira VM, Matthews PM, Robson MD, et al. Diffuse myocardial fibrosis and inflammation in rheumatoid arthritis: Insights from CMR T1 mapping. JACC: Cardiovascular Imaging. 2015;8(5):526–36. DOI: https://doi.org/10.1016/j.jcmg.2014.12.025
Dhahri R, Houaida M, Dergaa I, Ben Ammar L, Ceylan Hİ, Ben Abderrazek Y, et al. Myocardial impairment in rheumatoid arthritis patients with normal left ventricular function: Findings from speckle tracking echocardiography. Frontiers in Medicine (Lausanne). 2025;12:1530622. DOI: https://doi.org/10.3389/fmed.2025.1530622
Rho YH, Chung CP, Oeser A. The risk of cardiovascular disease in patients with rheumatoid arthritis: A population-based study. Arthritis & Rheumatism. 2009;60(6):1724–32. DOI: https://doi.org/10.1002/art.24626
Davis JM 3rd, Maradit Kremers H, Crowson CS, Nicola PJ, Ballman KV, Therneau TM, et al. Glucocorticoids and cardiovascular events in rheumatoid arthritis: A population-based cohort study. Arthritis & Rheumatism. 2007;56(3):820–30. DOI: https://doi.org/10.1002/art.22418
Giles JT, Fernandes V, Lima JA, Bathon JM. Myocardial dysfunction in rheumatoid arthritis: Epidemiology and pathogenesis. Arthritis Research & Therapy. 2005;7(5):195–207. DOI: https://doi.org/10.1186/ar1814
Ratwatte S, Day M, Ridley LJ, Fung C, Naoum C, Yiannikas J. Cardiac manifestations of IgG4-related disease: A case series. European Heart Journal – Case Reports. 2022;6(4):ytac153. DOI: https://doi.org/10.1093/ehjcr/ytac153
Kamisawa T, Zen Y, Pillai S, Stone JH. IgG4-related disease. The Lancet. 2015;385(9976):1460–71. DOI: https://doi.org/10.1016/S0140-6736(14)60720-0
Lee WK, Ng TS, Tan TE. Myocardial pseudotumor in IgG4-related disease. Journal of Cardiovascular Magnetic Resonance. 2019;21(1):10.
Yamamoto M, Takahashi H, Shinomura Y. IgG4-related periaortitis and aneurysm: Clinical features and outcomes. Annals of Vascular Surgery. 2017;40:298–305.
Okazaki K, Umehara H. Valvular involvement in IgG4-related disease: Case report and review. Heart and Vessels. 2016;31(8):1305–9.
Kasashima S, Zen Y. IgG4-related inflammatory abdominal aortic aneurysm. Current Opinion in Rheumatology. 2011;23(1):18–23. DOI: https://doi.org/10.1097/BOR.0b013e32833ee95f
Wallace ZS, Deshpande V, Mattoo H, Mahajan VS, Kulikova M, Pillai S, et al. IgG4-related disease: Clinical and laboratory features in one hundred twenty-five patients. Arthritis & Rheumatology. 2015;67(9):2466–75. DOI: https://doi.org/10.1002/art.39205
Sakamoto A, Nagai R, Saito A. IgG4-related disease with cardiac involvement. European Journal of Cardio-Thoracic Surgery. 2013;43(4):e105–7.
Vaglio A, Palmisano A, Corradi D, et al. IgG4-related disease: Clinical and pathophysiological aspects. Autoimmunity Reviews. 2013;12(5):542–5.
Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD). Modern Rheumatology. 2012;22(1):21–30. DOI: https://doi.org/10.3109/s10165-011-0571-z
Chang S, Lee SC, Kim DK, et al. Aortic involvement in IgG4-related disease: Imaging findings. Korean Circulation Journal. 2017;47(6):911–5.
Appleton CP, Hatle LK, Popp RL. Influence of preload and afterload on Doppler transmitral flow velocity patterns in dogs. Journal of the American College of Cardiology. 1988;11(2):327–32.
Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, et al. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. Journal of the American College of Cardiology. 2009;53(17):1475–87. DOI: https://doi.org/10.1016/j.jacc.2009.02.007
Ebbo M, Grados A, Daniel L, Vély F, Harlé JR, Pavic M, et al. IgG4-related systemic disease: Emergence of a new systemic disease? Literature review. Revue de Médecine Interne. 2012;33(1):23–34. DOI: https://doi.org/10.1016/j.revmed.2011.08.012
Ntusi NAB, Francis JM, Gumedze F, Karvounis H, Matthews PM, Wordsworth PB, et al. Cardiovascular magnetic resonance characterization of myocardial and vascular function in rheumatoid arthritis patients. Hellenic Journal of Cardiology. 2019;60(1):28–35. DOI: https://doi.org/10.1016/j.hjc.2018.01.008
Kamisawa T, Okazaki K, Kawa S. Diagnostic criteria for autoimmune pancreatitis in Japan. World Journal of Gastroenterology. 2008;14(32):4992–4. DOI: https://doi.org/10.3748/wjg.14.4992
Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: A scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Journal of the American College of Cardiology. 2007;50(19):1914–31. DOI: https://doi.org/10.1161/CIRCULATIONAHA.107.186093
Crowson CS, Liao KP, Davis JM 3rd, Solomon DH, Matteson EL, Knutson KL, et al. Rheumatoid arthritis and cardiovascular disease. American Heart Journal. 2013;166(4):622–8. DOI: https://doi.org/10.1016/j.ahj.2013.07.010
Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. The Lancet. 2016;388(10055):2023–38. DOI: https://doi.org/10.1016/S0140-6736(16)30173-8
Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation. 2003;107(9):1303–7. DOI: https://doi.org/10.1161/01.CIR.0000054612.26458.B2
Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. New England Journal of Medicine. 2017;377(12):1119–31. DOI: https://doi.org/10.1056/NEJMoa1707914
Downloads
Published
How to Cite
Issue
Section
